White Paper · 2025
Curated from findings from the inaugural Global Cannabis Regulatory Summit, held in Washington, D.C. on 26–27 March 2025, this white paper lays out a roadmap for a harmonised international cannabis economy. It recommends unified health-related cannabis frameworks, rigorous quality-control standards, and patient-centred access models, while distilling lessons from mature markets to guide emerging programmes worldwide.
Complete the form below and you will see a link to download the white paper directly.
DownloadOverview
The global cannabis industry is developing at a rapid pace, with regulatory change at the national level being the key driver of international market development. In the absence of meaningful change at the international level, each country pursues its own approach to cannabis policy.
The number of countries participating in the international trade of health-related cannabis is expanding, yet supply continues to outstrip demand and patient access remains restricted on a global scale, limited by insufficient training for healthcare professionals, bureaucratic obstacles to prescribing, institutional stigma, and the costs attached to those barriers.
The white paper distils hard-won lessons from mature markets to guide emerging programmes worldwide, and concludes with a call for sustained public-private collaboration to translate its recommendations into policy and practice.
Key Findings
At the heart of meaningful reform must be a steadfast commitment to the patient. The paper argues this remains the guiding principle if cannabis is to gain the political support needed to shed long-standing stigma and be treated as an effective health-related product.
Since the UN reclassification of cannabis in December 2020, policy is evolving rapidly, particularly across Europe, where several countries are both rescheduling and expanding their frameworks. Public perception has shifted profoundly alongside it.
Political hesitation, often rooted in stigma or the vested interests of entrenched industries, continues to obstruct rational, evidence-based policy that prioritises health and the public good.
The paper recommends harmonised health-related cannabis frameworks, rigorous quality-control standards, and patient-centred access models as the foundation of an international regulated economy.
Download
Complete the form and a download link will appear immediately.
Washington, D.C. · 26–27 March 2025